News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
226 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (4)
2 (2)
3 (20)
4 (246)
5 (293)
6 (243)
7 (134)
8 (6)
9 (6)
10 (245)
11 (212)
12 (305)
13 (245)
14 (103)
15 (11)
16 (7)
17 (226)
18 (253)
19 (250)
20 (220)
21 (147)
22 (16)
23 (11)
24 (235)
25 (299)
26 (248)
27 (114)
28 (103)
29 (10)
30 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
Owlstone Medical Appoints Dr Andy Richards CBE to Board of Directors
Owlstone Medical Ltd. announced today the addition of Dr Andy Richards CBE to its Board as a Non-Executive Director.
September 17, 2018
·
5 min read
Business
Ergomed plc: Notice of Interim Results for the Six Months Ended 30 June 2018
Ergomed plc will announce its interim results for the six months ended 30 June 2018 on Wednesday 19th September 2018.
September 17, 2018
·
1 min read
Business
INNATE PHARMA REPORTS FIRST HALF 2018 FINANCIAL RESULTS AND BUSINESS UPDATE
Preliminary anti-tumor activity for lead asset, monalizumab, in combination with cetuximab in advanced head and neck cancer and durvalumab in microsatellite-stable colorectal cancer presented at medical conferences
September 17, 2018
·
11 min read
Drug Development
Bone Therapeutics announces final results from Phase I/IIA ALLOB delayed-union fracture study
Optimized production process delivering critical improvements for future commercial use to be applied to all allogeneic platform clinical trials
September 17, 2018
·
8 min read
Hitachi’s First Dedicated Compact Proton Therapy System to be Supplied to Tokushukai Medical Group
System will be Installed at Shonan Kamakura Advanced Medical Center, Scheduled to be Complete in September 2020
September 17, 2018
·
3 min read
Policy
FDA’s Gottlieb Issues Agency Marching Orders to Fight Antimicrobial Resistance
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb gave a talk at The Pew Charitable Trusts on Friday, September 14, outlining the agency’s new approach to dealing with antimicrobial resistance (AMR).
September 17, 2018
·
3 min read
·
Mark Terry
Kanazawa University research: Mechanism of biological noise cancellation revealed
Researchers at Kanazawa University report in Scientific Reports how a particular biochemical signaling pathway cancels biological noise, ensuring the proper stem cell differentiation during development.
September 17, 2018
·
4 min read
Microdispensing of adhesives
Perfect dispensing results in the μl area using the endless piston principle
September 17, 2018
·
6 min read
Biotech Beach
Disruptions and Future Trends Shaping Bio-Tech Industry Investments Reveal Los Angeles as New Node
Event Bolsters Los Angeles as a National Biotech Hub
September 17, 2018
·
2 min read
Drug Development
Pfizer News: Alopecia Drugs Show Promise, and Company Inks Deal with Atomwise
Pfizer announced results from its Phase IIa clinical trial of PF-06651600 and PF-06700841 in alopecia areata (AA).
September 17, 2018
·
3 min read
·
Mark Terry
1 of 23
Next